Pharmaceutics · 2022 · 12 citations · 21 references
PharmacyImmunologyPharmacologyDrug DeliveryInflammationNanoparticle Drug DeliveryGut MicrobiotaInflammatory Bowel DiseaseLipid-based Drug Delivery SystemsLipid-based NanoparticlesNanocarriers For TherapeuticsNanomaterials For Drug DeliveryGut Microbiota CompositionLipid Drug EncapsulationLipid Nanoparticle DeliveryLipid Nanoparticle Delivery SystemsLipid NanoparticlesMetabolomic ChangesMicrobiome-associated MetabolitesMicrobiota-derived Metabolites
Modulating the gut microbiota composition is a potent approach to treat various chronic diseases, including obesity, metabolic syndrome, and ulcerative colitis (UC). However, the current methods, such as fecal microbiota transplantation, carry a risk of serious infections due to the transmission of multi-drug-resistant organisms. Here, we developed an organism-free strategy in which the gut microbiota is modulated ex vivo and microbiota-secreted metabolites are transferred back to the host. Using feces collected from the interleukin-10 (IL-10) knockout mouse model of chronic UC, we found that a drug candidate (M13)-loaded natural-lipid nanoparticle (M13/nLNP) modified the composition of the ex vivo-cultured inflamed gut microbiota and its secreted metabolites. Principal coordinate analysis (PCoA) showed that M13/nLNP shifted the inflamed microbiota composition toward the non-inflamed direction. This compositional modification induced significant changes in the chemical profiles of secreted metabolites, which proved to be anti-inflammatory against in vitro-cultured NF-κβ reporter cells. Further, when these metabolites were orally administered to mice, they established strong protection against the formation of chronic inflammation. Our study demonstrates that ex vivo modulation of microbiota using M13/nLNP effectively reshaped the microbial secreted metabolites and that oral transfer of these metabolites might be an effective and safe therapeutic approach for preventing chronic UC.
21
NF-κB signaling in inflammation
Ting Liu, Lingyun Zhang, Donghyun Joo et al. · Signal Transduction and Targeted Therapy · 2017 · 8.1K citations · Full text
Life Sciences, Immunology, Pathology +17
Sudabeh Alatab, Sadaf G Sepanlou, Kevin S Ikuta et al. · The Lancet. Gastroenterology & hepatology · 2019 · 2.3K citations · Full text
Public Health, Chronic Disease Prevention, Health Sciences +17
Plant-Derived Exosomal MicroRNAs Shape the Gut Microbiota
Yun Teng, Yi Ren, Mohammed Sayed et al. · Cell Host & Microbe · 2018 · 974 citations · Full text